Prolactin in CSF selectively increases dopamine turnover in the median eminence.
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007276:Injections, Intraventricular; D008297:Male; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism*; D008781:Methyltyrosines / Q000494:pharmacology; D009830:Olfactory Bulb / Q000187:drug effects / Q000378:metabolism; D011388:Prolactin / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000494:pharmacology; D051381:Rats
D008781:Methyltyrosines; D011388:Prolactin; D004298:Dopamine